(13-128) Evaluation of a Novel Guideline for Managing Oral Factor Xa Inhibitor to Intravenous Unfractionated Heparin Transitions by Utilizing Baseline Anti-Factor Xa Levels

Wednesday, December 7, 2022

3:15 PM – 4:15 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Cardiology/Anticoagulation

Co-Author(s): Tiffany Ladow, Charlotte Farris

Primary Author(s)

Koren M. Dunn, PharmD
Pharmacy Resident
Baylor Scott & White Hospital Temple, Texas